Boston Scientific shared the results during a late-breaking presentation at this year’s EHRA congress in Paris, France.
Stroke and systemic embolism occur at a low rate after catheter-based atrial ablation and may result in substantial sequelae or even death in certain cases.
Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S.
Morning Overview on MSN
New catheter aims to improve arrhythmia treatment as clinical trials begin
For the roughly 6 million Americans living with atrial fibrillation, catheter ablation has become an increasingly common ...
The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...
Medical Device Network on MSN
Sonire Therapeutics raises $18m for tumour ablation platform advancement
Sonire said the Series A funds will allow it to complete the randomised control trial of its high-intensity focused ...
The Society of Interventional Radiology (SIR) announced that the CAPTAIN randomized clinical trial found that men with ...
Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Tailored ablation guided by AI better prevented atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results